Table 2 RCT patient participants’ baseline characteristics
Variable, N (%) unless otherwise specified | Intervention Group 1 (15) | Control Group 2 (16) |
|---|---|---|
 Female gender | 10 (67) | 10 (62) |
 Age, mean (range), years | 37.00 (31) | 39.13 (33) |
Education | ||
 Up to 16 | 1 (6.6) | 2 (12.5) |
 Up to 18 | 0 | 1 (6.2) |
 Higher education | 14 (93.3) | 13 (81.2) |
Marital status | ||
 Married/living with partner | 9 (60) | 11 (68.7) |
 Widowed/divorced | 2 (13.3) | 0 |
 Single/single parent/Other | 4 (26.7) | 5 (31.2) |
Employment status | ||
 Full time/part time | 14 (93.3) | 13 (81.2) |
 Retired | 0 | 0 |
 Not working/housekeeping | 1 (6.6) | 3 (18.8) |
Living status | ||
 Alone | 2 (13.3) | 3 (18.8) |
 With partner/spouse/child/ other relatives/friends | 13 (86.7) | 13 (81.2) |
Smoking status | ||
 Yes | 0 | 1 (6.2) |
 Ex-smoker | 5 (33.3) | 9 (56.2) |
 No | 10 (66.7) | 6 (37.5) |
Exercise status (weekly) | ||
 > 30 min aerobic exercise | 12 (80) | 10 (62.5) |
 < 30 min aerobic exercise | 3 (20) | 6 (37.5) |
Disease classification | ||
 UC | 3 (20) | 4 (25) |
 CD | 11 (73.4) | 10 (62.5) |
 IBDU | 1 (6.6) | 2 (12.5) |
CD Montreal classification (n = 20) | ||
 L1 ileal | 6 (60) | 3 (30) |
 L2 colonic | 0 | 4 (40) |
 L3 ileocolonic | 4 (40) | 3 (30) |
Months since diagnosis, median (range) | 171.13 (879) | 217.00 (972) |
Current medication (yes) n (%) | 10 (67) | 14 (87) |
 Thiopurines | 6 | 6 |
 Methotrexate | 0 | 1 |
 Anti-TNF | 7 | 4 |
 Vedolizumab | 0 | 2 |
 Steroids | 0 | 1 |
Previous IBD surgery (yes) n (%) | 1 (6.67) | 4 (25) |
Current stoma (yes) n (%) | 0 | 1 (6.2) |